Overview

Effect of Sildenafil for Sustained PAH After MV Surgery (SUPERIOR Trial)

Status:
Terminated
Trial end date:
2018-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Sildenafil is effective in the treatment of sustained pulmonary artery hypertension after corrected mitral valve disease.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Asan Medical Center
Treatments:
Sildenafil Citrate